Oruka Therapeutics, Inc.

Oruka is Advancing novel biologics that aim to offer the greatest possible freedom from disease to people with plaque psoriasis and other associated conditions. Oruka mission—derived from or, for “skin,” and arukah, for “restoration.” They are seasoned biopharma professionals and drug developers committed to improving the experiences of people living with plaque psoriasis, psoriatic arthritis…More, and other dermatologic and inflammatory indications. They are advancing potentially best-in-class monoclonal antibodies designed to set a new treatment standard for psoriasis and other related diseases by delivering higher rates of complete disease clearance with as few as one or two doses per year.